People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cervel Neurotech, Inc. | — | Other Health Care | Series A | $37.2M | $20.2M | 2009 |
| Act Biotech Inc | — | Biotechnology | Pre-Seed | $2.5M | $55.2M | 2009 |
Gary Lazar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary Lazar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sami Hamade | 1 | 6 |
| Georg Nebgen | 1 | 5 |
| Vincent Kim | 1 | 4 |
| Michael Partsch | 1 | 4 |
| Guy Anthony | 1 | 4 |
| Eric Meier | 1 | 3 |
| John Mahoney | 1 | 3 |
| Vince Kim | 1 | 2 |
| John Sadler | 1 | 2 |
| Alexander Wong | 1 | 2 |
| John Costantino | 1 | 2 |
| Nils C. Behnke | 1 | 1 |
| Stephen Graham | 1 | 1 |
| Stephen M. Graham | 1 | 1 |
| John M. Sadler | 1 | 1 |
| Wolf-Dieter Busse | 1 | 1 |
| Ali Fattaey | 1 | 1 |
| M. Bret Schneider | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.